Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2016 Oct 14;10(10):CD006380.
doi: 10.1002/14651858.CD006380.pub3.

Pharmacologic interventions for treating phantom limb pain

Maria Jenelyn M Alviar  1 , Tom Hale, Monalisa Dungca
Affiliations
Meta-Analysis

Pharmacologic interventions for treating phantom limb pain

Maria Jenelyn M Alviar et al. Cochrane Database Syst Rev. .

Abstract

Background: This is an updated version of the original Cochrane review published in Issue 12, 2011. Phantom limb pain (PLP) is pain that arises in the missing limb after amputation and can be severe, intractable, and disabling. Various medications have been studied in the treatment of phantom pain. There is currently uncertainty in the optimal pharmacologic management of PLP.

Objectives: This review aimed to summarise the evidence of effectiveness of pharmacologic interventions in treating PLP.

Search methods: For this update, we searched the Cochrane Central Register of Controlled Trials (CENTRAL, the Cochrane Library), MEDLINE, and Embase for relevant studies. We ran the searches for the original review in September 2011 and subsequent searches for this update up to April 2016. We sought additional studies from clinical trials databases and reference lists of retrieved papers.

Selection criteria: We included randomised and quasi-randomised trials studying the effectiveness of pharmacologic interventions compared with placebo, another active treatment, or no treatment, in established PLP. We considered the following outcomes: change in pain intensity, function, sleep, depression or mood, quality of life, adverse events, treatment satisfaction, and withdrawals from the study.

Data collection and analysis: We independently assessed issues of study quality and extracted efficacy and adverse event data. Due to the wide variability in the studies, we did not perform a meta-analysis for all the interventions and outcomes, but attempted to pool the results of some studies where possible. We prepared a qualitative description and narrative summary of results. We assessed clinical heterogeneity by making qualitative comparisons of the populations, interventions, outcomes/outcome measures, and methods.

Main results: We added only one new study with 14 participants to this updated review. We included a 14 studies (10 with low risk of bias and 4 with unclear risk of bias overall) with a total of 269 participants. We added another drug class, botulinum neurotoxins (BoNTs), in particular botulinum toxin A (BoNT/A), to the group of medications reviewed previously. Our primary outcome was change in pain intensity. Most studies did not report our secondary outcomes of sleep, depression or mood, quality of life, treatment satisfaction, or withdrawals from the study.BoNT/A did not improve phantom limb pain intensity during the six months of follow-up compared with lidocaine/methylprednisolone.Compared with placebo, morphine (oral and intravenous) was effective in decreasing pain intensity in the short term with reported adverse events being constipation, sedation, tiredness, dizziness, sweating, voiding difficulty, vertigo, itching, and respiratory problems.The N-methyl D-aspartate (NMDA) receptor antagonists ketamine (versus placebo; versus calcitonin) and dextromethorphan (versus placebo), but not memantine, had analgesic effects. The adverse events of ketamine were more serious than placebo and calcitonin and included loss of consciousness, sedation, hallucinations, hearing and position impairment, and insobriety.The results for gabapentin in terms of pain relief were conflicting, but combining the results favoured treatment group (gabapentin) over control group (placebo) (mean difference -1.16, 95% confidence interval -1.94 to -0.38; 2 studies). However, gabapentin did not improve function, depression score, or sleep quality. Adverse events experienced were somnolence, dizziness, headache, and nausea.Compared with an active control benztropine mesylate, amitriptyline was not effective in PLP, with dry mouth and dizziness as the most frequent adverse events based on one study.The findings for calcitonin (versus placebo; versus ketamine) and local anaesthetics (versus placebo) were variable. Adverse events of calcitonin were headache, vertigo, drowsiness, nausea, vomiting, and hot and cold flushes. Most of the studies were limited by their small sample sizes.

Authors' conclusions: Since the last version of this review, we identified another study that added another form of medical therapy, BoNTs, specifically BoNT/A, to the list of pharmacologic interventions being reviewed for clinical efficacy in phantom limb pain. However, the results of this study did not substantially change the main conclusions. The short- and long-term effectiveness of BoNT/A, opioids, NMDA receptor antagonists, anticonvulsants, antidepressants, calcitonins, and local anaesthetics for clinically relevant outcomes including pain, function, mood, sleep, quality of life, treatment satisfaction, and adverse events remain unclear. Based on a small study, BoNT/A (versus lidocaine/methylprednisolone) does not decrease phantom limb pain. Morphine, gabapentin, and ketamine demonstrate favourable short-term analgesic efficacy compared with placebo. Memantine and amitriptyline may not be effective for PLP. However, results must be interpreted with caution, as they were based mostly on a small number of studies with limited sample sizes that varied considerably and also lacked long-term efficacy and safety outcomes. The direction of efficacy of calcitonin, local anaesthetics, and dextromethorphan needs further clarification. Overall, the efficacy evidence for the reviewed medications is thus far inconclusive. Larger and more rigorous randomised controlled trials are needed for us to reach more definitive conclusions about which medications would be useful for clinical practice.

PubMed Disclaimer

Conflict of interest statement

MJA: none known. MJA is a Rehabilitation Medicine specialist and has completed PhD Research in Orthopaedic Rehabilitation.

TAH: none known. TAH is a Rehabilitation physician and manages patients with amputations and complications including phantom limb pain.

MD: none known. MD is a Rehabilitation Medicine specialist and manages both adult and paediatric patients with musculoskeletal and neurologic conditions including patients with neuropathic pain.

Figures

1
1
Study flow diagram.
2
2
Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies.
3
3
Risk of bias summary: review authors' judgements about each risk of bias item for each included study.
1.1
1.1. Analysis
Comparison 1: Memantine versus placebo, Outcome 1: Change in pain intensity
2.1
2.1. Analysis
Comparison 2: Gabapentin versus placebo, Outcome 1: Change in pain intensity
See this image and copyright information in PMC

Update of

References

References to studies included in this review

Abraham 2003 {published data only}
    1. Abraham R, Marouani N, Weinbroum A. Dextromethorphan mitigates phantom pain in cancer amputees. Annals of Surgical Oncology 2003;10(3):268-74. - PubMed
Bone 2002 {published data only}
    1. Bone M, Critchley P, Buggy D. Gabapentin in postamputation phantom limb pain: a randomized, double-blind, placebo-controlled, cross-over study. Regional Anesthesia and Pain Medicine 2002;27(5):481-6. - PubMed
Casale 2009 {published data only}
    1. Casale R, Ceccherelli F, Labeeb A, Biella G. Phantom limb pain relief by contralateral myofascial injection with local anaesthetic in a placebo-controlled study: preliminary results. Journal of Rehabilitation Medicine 2009;41(6):418-22. - PubMed
Eichenberger 2008 {published data only}
    1. Eichenberger U, Neff F, Sveticic G, Bjorgo S, Petersen-Felix S, Arendt-Nielsen L, et al. Chronic phantom limb pain: the effects of calcitonin, ketamine, and their combination on pain and sensory thresholds. Anesthesia & Analgesia 2008;106(4):1265-73. - PubMed
Huse 2001 {published data only}
    1. Huse E, Larbig W, Flor H, Birbaumer N. The effect of opioids on phantom limb pain and cortical reorganization. Pain 2001;90(1-2):47-55. - PubMed
Jaeger 1992 {published data only}
    1. Jaeger H, Maier C. Calcitonin in phantom limb pain: a double-blind study. Pain 1992;48(1):21-7. - PubMed
Maier 2003 {published data only}
    1. Maier C, Dertwinkel R, Mansourian N, Hosbach I, Schwenkreis P, Senne I, et al. Efficacy of the NMDA-receptor antagonist memantine in patients with chronic phantom limb pain - results of a randomized double-blinded, placebo-controlled trial. Pain 2003;103(3):277-83. - PubMed
Nikolajsen 1996 {published data only}
    1. Nikolajsen L, Hansen C, Nielsen J, Keller J, Arendt-Nielsen L, Jensen T. The effect of ketamine on phantom pain: a central neuropathic disorder maintained by peripheral input. Pain 1996;67(1):69-77. - PubMed
Robinson 2004 {published data only}
    1. Robinson L, Czerniecki J, Ehde D, Edwards T, Judish D, Goldberg M, et al. Trial of amitriptyline for relief of pain in amputees: results of a randomized controlled study. Archives of Physical Medicine and Rehabilitation 2004;85(1):1-6. - PubMed
Schwenkreis 2003 {published data only}
    1. Schwenkreis P, Maier C, Pleger B, Mansourian N, Dertwinkel R, Malin J-P, et al. NMDA-mediated mechanisms in cortical excitability changes after limb amputation. Acta Neurologica Scandinavica 2003;108(3):179-84. - PubMed
Smith 2005 {published data only}
    1. Smith D, Ehde D, Hanley M, Campbell K, Jensen M, Hoffman A, et al. Efficacy of gabapentin in treating chronic phantom limb and residual limb pain. Journal of Rehabilitation Research & Development 2005;42(5):645-54. - PubMed
Wiech 2004 {published data only}
    1. Wiech K, Kiefer RT, Topfner S, Preissl H, Braun C, Unertl K, et al. A placebo-controlled randomized crossover trial of the N-methyl-D-aspartic acid receptor antagonist, memantine, in patients with chronic phantom limb pain. Anesthesia & Analgesia 2004;98(2):408-13. - PubMed
Wu 2002 {published data only}
    1. Wu C, Tella P, Staats P, Vaslav R, Kazim D, Wesselmann U, et al. Analgesic effects of intravenous lidocaine and morphine on postamputation pain. Anesthesiology 2002;96(2):841-8. - PubMed
Wu 2012 {published data only}
    1. Wu H, Sultana R, Taylor KB, Szabo A. A prospective randomized double-blinded pilot study to examine the effect of botulinum toxin type A injection versus Lidocaine/Depomedrol injection on residual and phantom limb pain: initial report. Clinical Journal of Pain 2012;28(2):108-12. - PMC - PubMed

References to studies excluded from this review

Abraham 2002 {published data only}
    1. Abraham R, Marouani N, Kollender Y, Meller I, Weinbroum A. Dextromethorphan for phantom pain attenuation in cancer amputees: a double-blind crossover trial involving three patients. Clinical Journal of Pain 2002;18(5):282-5. - PubMed
Atesalp 2000 {published data only}
    1. Ateşalp AS, Özkan Y, Kömürcü M, Erler K, Işımer A, Güret E. The effects of capsaicin in phantom limb pain [Fantom ekstremite ağrısında kapsaisinin etkileri]. Agri 2000;12(2):30-3.
Borghi 2010 {published data only}
    1. Borghi B, D'Addabbo M, White PF, Gallerani P, Toccaceli L, Raffaeli W, et al. The use of prolonged peripheral neural blockade after lower extremity amputation: the effect on symptoms associated with phantom limb syndrome. Anesthesia & Analgesia 2010;111(5):1308-15. - PubMed
Cohen 2011 {published data only}
    1. Cohen SP, Gambel JM, Raja SN, Galvagno S. The contribution of sympathetic mechanisms to postamputation phantom and residual limb pain: a pilot study. Journal of Pain 2011;12(8):859-67. - PubMed
Elizaga 1994 {published data only}
    1. Elizaga AM, Smith DG, Sharar SR, Edwards WT, Hansen ST Jr. Continuous regional analgesia by intraneural block: effect on postoperative opioid requirements and phantom limb pain following amputation. Journal of Rehabilitation and Development 1994;31(3):179-87. - PubMed
Elrazek 2005 {published data only}
    1. Elrazek EA. The analgesic effects of epidural diamorphine and levobupivacaine on established lower limb post-amputation stump pain - a comparative study. Middle East Journal of Anesthesiology 2005;18(1):149-60. - PubMed
Grant 2008 {published data only}
    1. Grant AJ, Wood C. The effect of intra-neural local anaesthetic infusion on pain following major lower limb amputation. Scottish Medical Journal 2008;53(1):4-6. - PubMed
Ilfeld 2013 {published data only}
    1. Ilfeld BM, Moeller‐Bertram T, Hanling SR, Tokarz K, Mariano ER, Loland VJ, et al. Treating intractable phantom limb pain with ambulatory continuous peripheral nerve blocks: a pilot study. Pain Medicine 2013;14(6):935-42. - PMC - PubMed
Jacobson 1989 {published data only}
    1. Jacobson L, Chabala C, Brody M. Relief of persistent postamputation stump and phantom limb pain with intrathecal fentanyl. Pain 1989;37(3):317-22. - PubMed
Jacobson 1990 {published data only}
    1. Jacobson L, Chabal C, Brody MC, Mariano AJ, Chaney EF. A comparison of the effects of intrathecal fentanyl and lidocaine on established postamputation stump pain. Pain 190;40(2):137-41. - PubMed
Jaeger 1988 {published data only}
    1. Jaeger H, Maier C, Wawersik J. Postoperative treatment of phantom pain and causalgias with calcitonin. Anaesthesist 1988;37(2):71-7. - PubMed
Jin 2009 {published data only}
    1. Jin L, Kollewe K, Krampfl K, Dengler R, Mohammadi B. Treatment of phantom limb pain with botulinum toxin type A. Pain Medicine 2009;10(2):300-3. - PubMed
Karanikolas 2011 {published data only}
    1. Karanikolas M, Aretha D, Tsolakis I, Monantera G, Kiekkas P, Papadoulas S, et al. Optimized perioperative analgesia reduces chronic phantom limb pain intensity, prevalence, and frequency: a prospective, randomized, clinical trial. Anesthesiology 2011;114(5):1144-54. - PubMed
Kessel 1987 {published data only}
    1. Kessel C, Wörz R. Immediate response of phantom limb pain to calcitonin. Pain 1987;30(1):79-87. - PubMed
Kukushkin 1996 {published data only}
    1. Kukushkin ML, Ivanova AF, Ovechkin AM, Gnezdilov AV, Reshetniak VK. Differential combined drug therapy of phantom pain syndrome after amputation of extremity. Anesteziologiia i Reanimatologiia 1996;4:39-42. - PubMed
Licina 2013 {published data only}
    1. Licina L, Hamsher C, Lautenschager K, Dhanjal S, Williams N, Spevak C. Buprenorphine/naloxone therapy for opioid refractory neuropathic pain following traumatic amputation: a case series. Military Medicine 2013;178(7):e858-61. - PubMed
Lirk 2012 {published data only}
    1. Lirk P, Stadlbauer KH, Hollmann MW. ESA Clinical Trials Network 2012: PLATA – Prevention of Phantom Limb Pain After Transtibial Amputation: Randomised, double-blind, controlled, multicentre trial comparing optimised intravenous pain control versus optimised intravenous pain control plus regional anaesthesia. European Journal of Anaesthesiology 2013;30(5):202-4. - PubMed
Neil 2012 {published data only}
    1. Neil MJ. Brachial plexus block in phantom limb pain: interesting, but limited clinical benefit in chronic setting. Pain Medicine 2012;13(6):849. - PubMed
Nikolajsen 1997 {published data only}
    1. Nikolajsen L, Hansen PO, Jensen TS. Oral ketamine therapy in the treatment of postamputation stump pain. Acta Anaesthesiologica Scandinavica 1997;41(3):427-9. - PubMed
Nikolajsen 2006 {published data only}
    1. Nikolajsen L, Finnerup NB, Kramp S, Vimtrup AS, Keller J, Jensen TS. A randomized study of the effects of gabapentin on postamputation pain. Anesthesiology 2006;105(5):1008-15. - PubMed
Panerai 1990 {published data only}
    1. Panerai AE, Monza G, Movilia P, Bianchi M, Francucci BM, Tiengo M. A randomized, within-patient, cross-over, placebo-controlled trial on the efficacy and tolerability of the tricyclic antidepressants chlorimipramine and nortriptyline in central pain. Acta Neurologica Scandinavica 1990;82(1):34-8. - PubMed
Pinzur 1996 {published data only}
    1. Pinzur MS, Garla PG, Pluth T, Vrbos L. Continuous postoperative infusion of a regional anesthetic after an amputation of the lower extremity. A randomized clinical trial. Journal of Bone and Joint Surgery. American volume 1996;78(10):1501-5. - PubMed
Rogers 1989 {published data only}
    1. Rogers AG. Use of amitriptyline (Elavil) for phantom limb pain in younger children. Journal of Pain & Symptom Management 1989;4(2):96. - PubMed
Sato 2008 {published data only}
    1. Sato K, Higuchi H, Hishikawa Y. Management of phantom limb pain and sensation with milnacipran. Journal of Neuropsychiatry & Clinical Neurosciences 2008;20(3):368. - PubMed
Scadding 1982 {published data only}
    1. Scadding JW, Wall PD, Parry CB, Brooks DM. Clinical trial of propranolol in post-traumatic neuralgia. Pain 1982;14(3):283-92. - PubMed
Van Seventer 2010 {published data only}
    1. Van Seventer R, Bach FW, Toth CC, Serpell M, Temple J, Murphy TK, et al. Pregabalin in the treatment of post-traumatic peripheral neuropathic pain: a randomized double-blind trial. European Journal of Neurology 2010;17(8):1082-9. - PubMed
Vorobeichik 1997 {published data only}
    1. Vorobeĭchik IaM, Kukushkin ML, Reshetniak VK, Ovechkin AM, Gnezdilov AV. The treatment of the phantom pain syndrome with tizanidine. Zh Nevrol Psikhiatr Im S S Korsakova 1997;97(3):36-9. - PubMed
Wilder‐Smith 2005 {published data only}
    1. Wilder-Smith CH, Hill LT, Laurent S. Postamputation pain and sensory changes in treatment-naive patients: characteristics and responses to treatment with tramadol, amitriptyline, and placebo. Anesthesiology 2005;103(3):619-28. - PubMed
Wu 2008 {published data only}
    1. Wu CL, Agarwal S, Tella PK, Klick B, Clark MR, Haythornthwaite JA, et al. Morphine versus mexiletine for treatment of postamputation pain: a randomized, placebo-controlled, crossover trial. Anesthesiology 2008;109(2):289-96. - PMC - PubMed

References to studies awaiting assessment

Buch 2019 {published data only}
    1. Buch NS, Ahlburg P, Haroutounian S, Anderson NT, Finnerup NB, Nikolajsen L. The role of afferent input in postamputation pain: a randomized, double-blind, placebo-controlled crossover study. Pain 2019;160(7):1622-33. [DOI: 10.1097/j.pain.0000000000001536] - DOI - PubMed

Additional references

Aoki 2001a
    1. Aoki KR. Pharmacology and immunology of botulinum toxin serotypes. Journal of Neurology 2001;248(1):I3-10. - PubMed
Aoki 2001b
    1. Aoki KR, Guyer B. Botulinum toxin type A and other botulinum toxin serotypes: a comparative review of biochemical and pharmacological actions. European Journal of Neurology 2001;8(s5):21-9. - PubMed
Azria 2002
    1. Azria M. Possible mechanisms of the analgesic action of calcitonin. Bone 2002;30(5):80S-3S. - PubMed
Bileviciute‐Ljungara 2001
    1. Bileviciute-Ljungara I, Biellab G, Bellomib P, Sotgiub M. Contralateral treatment with lidocaine reduces spinal neuronal activity in mononeuropathic rat. Neuroscience Letters 2001;311:157-60. - PubMed
Birbaumer 1997
    1. Birbaumer N, Lutzenberger W, Montoya P, Larbig W, Unertl K, Topfner S, et al. Effects of regional anesthesia on phantom limb pain are mirrored in changes in cortical reorganization. Journal of Neuroscience 1997;17(14):5503-8. - PMC - PubMed
Bolognini 2013
    1. Bolognini N, Olgiati E, Maravita A, Ferraro F, Fregni F. Motor and parietal cortex stimulation for phantom limb pain and sensations. Pain 2013;154(8):1274-80. - PubMed
Brin 1997
    1. Brin MF. Botulinum toxin: chemistry, pharmacology, toxicity, and immunology. Muscle Nerve Supplement 1997;6:S146-68. - PubMed
Burgoyne 2012
    1. Burgoyne L, Billups C, Jirón J, Kaddoum R, Wright B, Bikhazi G, et al. Phantom limb pain in young cancer-related amputees: recent experience at St. Jude Children’s Research Hospital. Clinical Journal of Pain 2012;28(3):222-5. - PMC - PubMed
Charrow 2008
    1. Charrow A, DiFazio M, Foster L, Pasquina PF, Tsao JW. Intradermal botulinum toxin type A injection effectively reduces residual limb hyperhidrosis in amputees: a case series. Archives of Physical Medicine and Rehabilitation 2008;89(7):1407-9. - PubMed
Clark 2013
    1. Clark RL, Bowling FL, Jepson F, Rajbhandari S. Phantom limb pain after amputation in diabetic patients does not differ from that after amputation in nondiabetic patients. Pain 2013;154(5):729-32. - PubMed
Darnall 2005
    1. Darnall BD, Ephraim P, Wegener ST, Dillingham T, Pezzin L, Rossbach P, et al. Depressive symptoms and mental health service utilization among persons with limb loss: results of a national survey. Archives of Physical Medicine and Rehabilitation 2005;86(4):650-8. - PubMed
Desmond 2010
    1. Desmond DM, MacLachlan M. Prevalence and characteristics of phantom limb pain and residual limb pain in the long term after upper limb amputation. International Journal of Rehabilitation Research 2010;33(3):279-82. - PubMed
Ehde 2000
    1. Ehde DM, Czerniecki JM, Smith DG, Campbell KM, Edwards WT, Jensen MP, et al. Chronic phantom sensations, phantom pain, residual limb pain, and other regional pain after lower limb amputation. Archives of Physical Medicine and Rehabilitation 2000;81(8):1039-44. - PubMed
Eisenberg 1998
    1. Eisenberg E, Kleiser A, Dortort A, Haim T, Yarnitsky D. The NMDA (N-methyl-D-aspartate) receptor antagonist memantine in the treatment of postherpetic neuralgia: a double-blind, placebo-controlled study. European Journal of Pain 1998;2(4):321-7. - PubMed
Elbert 1994
    1. Elbert T, Flor H, Birbaumer N, Knecht S, Hampson S, Larbig W, et al. Extensive reorganization of the somatosensory cortex in adult humans after nervous system injury. NeuroReport 1994;5(18):2593-7. - PubMed
Elbert 2004
    1. Elbert T, Rockstroh B. Reorganization of human cerebral cortex: the range of changes following use and injury. Neuroscientist 2004;10(2):129-41. - PubMed
Ephraim 2005
    1. Ephraim PL, Wegener ST, MacKenzie EJ, Dillingham TR, Pezzin LE. Phantom pain, residual limb pain, and back pain in amputees: results of a national survey. Archives of Physical Medicine and Rehabilitation 2005;86(10):1910-9. - PubMed
Finnerup 2015
    1. Finnerup NB, Attal N, Haroutounian S, McNicol E, Baron R, Dworkin RH, et al. Pharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysis. Lancet Neurology 2015;14(2):162-73. - PMC - PubMed
Flor 1995
    1. Flor H, Elbert T, Knecht S, Wienbruch C, Pantev C, Birbaumer N, et al. Phantom limb pain as a perceptual correlate of cortical reorganization following arm amputation. Nature 1995;375(6531):482-4. - PubMed
Foell 2011
    1. Foell J, Bekrater-Bodmann R, Flor H, Cole J. Phantom limb pain after lower limb trauma origins and treatments. International Journal of Lower Extremity Wounds 2011;10(4):224-35. - PubMed
Furlan 2006
    1. Furlan A, Sandoval J, Mailis Gagnon A, Tunks E. Opioids for chronic noncancer pain: a meta-analysis of effectiveness and side effects. Canadian Medical Association Journal 2006;174(11):1589-94. - PMC - PubMed
Furlan 2011
    1. Furlan AD, Chaparro LE, Irvin E, Mailis-Gagnon A. A comparison between enriched and nonenriched enrollment randomized withdrawal trials of opioids for chronic noncancer pain. Pain Research & Management: The Journal of the Canadian Pain Society 2011;16(5):337-51. - PMC - PubMed
Giummarra 2011
    1. Giummarra MJ, Moseley GL. Phantom limb pain and bodily awareness: current concepts and future directions. Current Opinion in Anesthesiology 2011;24(5):524-31. - PubMed
Halbert 2002
    1. Halbert J, Crotty M, Cameron ID. Evidence for the optimal management of acute and chronic phantom pain: a systematic review. Clinical Journal of Pain 2002;18(2):84-92. - PubMed
Hall 2013
    1. Hall GC, Morant, SV, Carroll D, Gabriel ZL, McQuay HJ. An observational descriptive study of the epidemiology and treatment of neuropathic pain in a UK general population. BMC Family Practice 2013;14(1):28. - PMC - PubMed
Hanley 2004
    1. Hanley MA, Jensen MP, Ehde DM, Hoffman AJ, Patterson DR, Robinson LR. Psychosocial predictors of long-term adjustment to lower-limb amputation and phantom limb pain. Disability & Rehabilitation 2004;26(14-15):882-93. - PubMed
Hanley 2009
    1. Hanley MA, Ehde DM, Jensen M, Czerniecki J, Smith DG, Robinson LR. Chronic pain associated with upper-limb loss. American Journal of Physical Medicine & Rehabilitation 2009;88(9):742-79. - PMC - PubMed
Higgins 2011
    1. Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from handbook.cochrane.org.
Jensen 1983
    1. Jensen TS, Krebs B, Nielsen J, Rasmussen P. Phantom limb, phantom pain and stump pain in amputees during the first 6 months following limb amputation. Pain 1983;17(3):243-56. - PubMed
Jensen 1985
    1. Jensen TS, Krebs B, Nielsen J, Rasmussen P. Immediate and long-term phantom limb pain in amputees: incidence, clinical characteristics and relationship to pre-amputation limb pain. Pain 1985;21(3):267-8. - PubMed
Jensen 2000
    1. Jensen TS, Nikolajsen L. Pre-emptive analgesia in postamputation pain: an update. Progress in Brain Research 2000;129:493-503. - PubMed
Kalso 2004
    1. Kalso E, Edwards J, Moore A, McQuay H. Opioids in chronic non-cancer pain: systematic review of efficacy and safety. Pain 2004;112(3):372-80. - PubMed
Katz 1990
    1. Katz J, Melzack R. Pain “memories” in phantom limbs: review and clinical observations. Pain 1990;43(3):319-36. - PubMed
Kern 2003
    1. Kern U, Martin C, Scheicher S, Müller H. Treatment of phantom pain with botulinum-toxin A. A pilot study [Abstract]. Schmerz 2003;17(2):117-24. - PubMed
Kern 2004a
    1. Kern U, Martin C, Scheicher S, Muller H. Does botulinum toxin A make prosthesis use easier for amputees? Journal of Rehabilitation Medicine 2004;36(5):238-9. - PubMed
Kern 2004b
    1. Kern U, Martin C, Scheicher S, Müller H. Long-term treatment of phantom and stump pain with Botulinum toxin type A over 12 months. A first clinical observation [Abstract]. Der Nervenarzt 2004;75(4):336-40. - PubMed
Kern 2011
    1. Kern U, Kohl M, Seifert U, Schlereth T. Botulinum toxin type B in the treatment of residual limb hyperhidrosis for lower limb amputees: a pilot study. American Journal of Physical Medicine & Rehabilitation 2011;90(4):321-9. - PubMed
Khanahmadi 2012
    1. Khanahmadi S, Skrabek R, Arneja A. Effect of nabilone on phantom limb pain [Conference Abstract]. Journal of Rehabilitation Medicine 2012;44(11):1004.
Lei 2004
    1. Lei LG, Sun S, Gao YJ, Zhao ZQ, Zhang YQ. NMDA receptors in the anterior cingulated cortex mediate pain-related aversion. Experimental Neurology 2004;189(2):413-21. - PubMed
Manchikanti 2004
    1. Manchikanti L, Singh V. Managing phantom pain. Pain Physician 2004;7(3):365-75. - PubMed
McCormick 2014
    1. McCormick Z, Chang‐Chien G, Marshall B, Huang M, Harden RN. Phantom limb pain: a systematic neuroanatomical‐based review of pharmacologic treatment. Pain Medicine 2014;15(2):292-305. - PubMed
McNicol 2013
    1. McNicol ED, Midbari A, Eisenberg E. Opioids for neuropathic pain. Cochrane Database of Systematic Reviews 2013, Issue 8. Art. No: CD006146. [DOI: 10.1002/14651858.CD006146.pub2] - DOI - PMC - PubMed
Millstein 1985
    1. Millstein S, Bain D, Hunter GA. A review of employment patterns of industrial amputees - factors influencing rehabilitation. Prosthetics and Orthotics International 1985;9(2):69-78. - PubMed
Montoya 1998
    1. Montoya P, Ritter K, Huse E, Larbig W, Braun C, Töpfner S, et al. The cortical somatotopic map and phantom phenomena in subjects with congenital limb atrophy and traumatic amputees with phantom limb pain. European Journal of Neuroscience 1998;10(3):1095-102. - PubMed
Moore 2005
    1. Moore RA, McQuay HJ. Prevalence of opioid adverse events in chronic non-malignant pain: systematic review of randomised trials of oral opioids. Arthritis Research & Therapy 2005;7(5):R1046-51. - PMC - PubMed
Moore 2014
    1. Moore RA, Wiffen PJ, Derry S, Toelle T, Rice ASC. Gabapentin for chronic neuropathic pain and fibromyalgia in adults. Cochrane Database of Systematic Reviews 2014, Issue 4. Art. No: CD007938. [DOI: 10.1002/14651858.CD007938.pub3] - DOI - PMC - PubMed
Moore 2015
    1. Moore RA, Derry S, Aldington D, Cole P, Wiffen PJ. Amitriptyline for neuropathic pain in adults. Cochrane Database of Systematic Reviews 2015, Issue 7. Art. No: CD008242. [DOI: 10.1002/14651858.CD008242.pub3] - DOI - PMC - PubMed
Moseley 2012
    1. Moseley GL, Flor H. Targeting cortical representations in the treatment of chronic pain a review. Neurorehabilitation and Neural Repair 2012;26(6):646-52. - PubMed
Moulin 2014
    1. Moulin DE, Boulanger A, Clark AJ, Clarke H, Dao T, Finley GA, et al. Pharmacological management of chronic neuropathic pain: revised consensus statement from the Canadian Pain Society. Pain Research and Management 2014;19(6):328-35. - PMC - PubMed
Nikolajsen 2000
    1. Nikolajsen L, Gottrup H, Kristensen A, Jensen T. Memantine (a n-methyl-d-aspartate receptor antagonist) in the treatment of neuropathic pain after amputation or surgery: a randomized, double-blinded, cross-over study. Anesthesia & Analgesia 2000;91(4):960-6. - PubMed
Nikolajsen 2001
    1. Nikolajsen L, Jensen TS. Phantom limb pain. British Journal of Anesthesia 2001;87(1):107-16. - PubMed
Penn‐Barwell 2011
    1. Penn-Barwell JG. Outcomes in lower limb amputation following trauma: a systematic review and meta-analysis. Injury 2011;42(12):1474-9. - PubMed
Pezzin 2000
    1. Pezzin LE, Dillingham TR, MacKenzie EJ. Rehabilitation and the long-term outcomes of persons with trauma-related amputations. Archives of Physical Medicine and Rehabilitation 2000;81(3):292-300. - PubMed
Preißler 2013
    1. Preißler S, Feiler J, Dietrich C, Hofmann GO, Miltner WH, Weiss T. Gray matter changes following limb amputation with high and low intensities of phantom limb pain. Cerebral Cortex 2013;23(5):1038-48. - PubMed
Ramachandran 1992
    1. Ramachandran VS, Rogers-Ramachandran D, Stewart M. Perceptual correlates of massive cortical reorganization. Science 1992;258(5085):1159-60. - PubMed
Reiber 2010
    1. Reiber GE, McFarland LV, Hubbard S, Maynard C, Blough DK, Gambel JM, et al. Servicemembers and veterans with major traumatic limb loss from Vietnam war and OIF/OEF conflicts: Survey methods, participants, and summary findings. Journal of Rehabilitation Research and Development 2010;47(4):275-98. - PubMed
Richardson 2006
    1. Richardson C, Glenn S, Nurmikko T, Horgan M. Incidence of phantom phenomena including phantom limb pain 6 months after major lower limb amputation in patients with peripheral vascular disease. Clinical Journal of Pain 2006;22(4):353-8. - PubMed
Robbins 2009
    1. Robbins CB, Vreeman DJ, Sothmann MS, Wilson SL, Oldridge NB. A review of the long-term health outcomes associated with war-related amputation. Military Medicine 2009;174(6):588-92. - PubMed
Schley 2007
    1. Schley M, Topfner S, Wiech K, Schaller H, Konrad C, Schmelz M, et al. Continuous brachial plexus blockade in combination with the NMDA receptor antagonist memantine prevents phantom pain in acute traumatic upper limb amputees. European Journal of Pain 2007;11(3):299-308. - PubMed
Sheehan 2014
    1. Sheehan TP, Gondo GC. Impact of limb loss in the United States. Physical Medicine & Rehabilitation Clinics of North America 2014;25:9-28. - PubMed
Sherman 1980
    1. Sherman RA. Published treatments of phantom limb pain. American Journal of Physical Medicine 1980;59(5):232-44. - PubMed
Sherman 1984
    1. Sherman RA, Sherman C, Parker L. Chrononic phantom and stump pain among American veterans: results of a survey. Pain 1984;18:83-95. - PubMed
Silberstein 2001
    1. Silberstein SD. Review of botulinum toxin type A and its clinical applications in migraine headache. Expert Opinion on Pharmacotherapy 2001;2:1649-54. - PubMed
Sin 2013
    1. Sin EI, Thong SY, Poon KH. Incidence of phantom limb phenomena after lower limb amputations in a Singapore tertiary hospital. Singapore Medical Journal 2013;54(2):75-81. - PubMed
Sinha 2011a
    1. Sinha R, Van Den Heuvel WJ. A systematic literature review of quality of life in lower limb amputees. Disability and Rehabilitation 2011;33(11):883-99. - PubMed
Sinha 2011b
    1. Sinha R, den Heuvel WJ, Arokiasamy P. Factors affecting quality of life in lower limb amputees. Prosthetics and Orthotics International 2011;35(1):90-6. - PubMed
Stansbury 2008
    1. Stansbury LG, Lalliss SJ, Branstetter JG, Bagg MR, Holcomb JB. Amputations in US military personnel in the current conflicts in Afghanistan and Iraq. Journal of Orthopaedic Trauma 2008;22(1):43-6. - PubMed
Tan 2010
    1. Tan T, Barry P, Reken S, Baker M. Guidelines: Pharmacological management of neuropathic pain in non-specialist settings: summary of NICE guidance. BMJ 2010;340(7748):707-70. - PubMed
Whyte 2002
    1. Whyte AS, Carroll LJ. A preliminary examination of the relationship between employment, pain and disability in an amputee population. Disability and Rehabilitation 2002;24(9):462-70. - PubMed
Wolff 2011
    1. Wolff A, Vanduynhoven E, Van Kleef M, Huygen F, Pope J, Mekhail N. Phantom pain. Pain Practice 2011;11(4):403-13. - PubMed
Woolf 2011
    1. Woolf CJ. Central sensitization: implications for the diagnosis and treatment of pain. Pain 2011;152(3):S2-15. - PMC - PubMed
Ziegler‐Graham 2008
    1. Ziegler-Graham K, MacKenzie EJ, Ephraim PL, Travison TG, Brookmeyer R. Estimating the prevalence of limb loss in the United States: 2005 to 2050. Archives of Physical Medicine and Rehabilitation 2008;89:42-9. - PubMed

Publication types

MeSH terms